Drug Patents owned by Sprout Pharms
1. List of Addyi drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7420057 | SPROUT PHARMS | Stable polymorph of flibanserin |
Aug, 2022
(9 months ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9468639 | SPROUT PHARMS | Treating sexual desire disorders with flibanserin |
Oct, 2022
(7 months ago) | |
| US8227471 | SPROUT PHARMS | Treating sexual desire disorders with flibanserin |
May, 2023
(22 days ago) | |
| US7151103 | SPROUT PHARMS | Method of treating female hypoactive sexual desire disorder with flibanserin |
May, 2028
(4 years from now) | |
Drugs and Companies using FLIBANSERIN ingredient
Market Authorisation Date: 18 August, 2015
Treatment: Use of flibanserin or a pharmaceutically acceptable acid addition salt thereof to treat hypoactive sexual desire disorder (hsdd)
Dosage: TABLET;ORAL
ADDYI family patents
23
United States
10
European Union
5
China
4
Brazil
4
Argentina
4
Japan
4
Korea, Republic of
2
Spain
2
Austria
2
Malaysia
2
Denmark
2
Germany
2
Poland
2
Yugoslavia
2
Canada
2
Ukraine
2
EA
2
Norway
2
New Zealand
2
Croatia
2
Israel
2
Portugal
2
Mexico
2
Australia
2
Ecuador
2
South Africa
2
Slovenia
2
Hungary
1
Hong Kong
1
ME
1
Colombia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic